| Authors: |
Dessau RB; Department of Clinical Microbiology, Slagelse Hospital, Region Sjælland, Denmark. Electronic address: ramd@regionsjaelland.dk., van Dam AP; OLVG General Hospital and Public Health Laboratory, Amsterdam, The Netherlands., Fingerle V; National Reference Centre for Borrelia, Munich, Oberschleissheim, Germany., Gray J; UCD School of Biology and Environmental Science, University College Dublin, Dublin, Ireland., Hovius JW; Centre for Experimental and Molecular Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands., Hunfeld KP; Northwest Medical Centre, Academic Teaching Hospital, Medical Faculty, Goethe-University, Frankfurt/Main and INSTAND e.V., Düsseldorf, Germany., Jaulhac B; National Reference Centre for Borrelia, Hôpitaux Universitaires de Strasbourg, France., Kahl O; Tick-radar GmbH, Berlin, Germany., Kristoferitsch W; Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, Vienna, Austria., Lindgren PE; Linköping University, Linköping, Sweden., Markowicz M; Institute for Hygiene and Applied Immunology, Medical University of Vienna, Vienna, Austria., Mavin S; National Lyme Borreliosis Testing Laboratory, Raigmore Hospital, Inverness, UK., Ornstein K; Division of Medicine, Skånevård Kryh, Region Skåne, Sweden., Rupprecht T; Department of Neurology, HELIOS Klinikum München West, Munich, Germany., Stanek G; Institute for Hygiene and Applied Immunology, Medical University of Vienna, Vienna, Austria., Strle F; Department of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia. |
